These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Unraveling the Role of Peroxisome Proliferator-Activated Receptor β/Δ (PPAR β/Δ) in Angiogenesis Associated with Multiple Myeloma. Leone P; Solimando AG; Prete M; Malerba E; Susca N; Derakhshani A; Ditonno P; Terragna C; Cavo M; Silvestris N; Racanelli V Cells; 2023 Mar; 12(7):. PubMed ID: 37048084 [TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor beta/delta as a therapeutic target for metabolic diseases. Bedu E; Wahli W; Desvergne B Expert Opin Ther Targets; 2005 Aug; 9(4):861-73. PubMed ID: 16083348 [TBL] [Abstract][Full Text] [Related]
10. The role of PPARβ/δ in the management of metabolic syndrome and its associated cardiovascular complications. Benetti E; Patel NS; Collino M Endocr Metab Immune Disord Drug Targets; 2011 Dec; 11(4):273-84. PubMed ID: 21696362 [TBL] [Abstract][Full Text] [Related]
11. Activation of peroxisome proliferator-activated receptor-β/δ (PPAR-β/δ) inhibits human breast cancer cell line tumorigenicity. Yao PL; Morales JL; Zhu B; Kang BH; Gonzalez FJ; Peters JM Mol Cancer Ther; 2014 Apr; 13(4):1008-17. PubMed ID: 24464939 [TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels. Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106 [TBL] [Abstract][Full Text] [Related]
13. Three members of the human pyruvate dehydrogenase kinase gene family are direct targets of the peroxisome proliferator-activated receptor beta/delta. Degenhardt T; Saramäki A; Malinen M; Rieck M; Väisänen S; Huotari A; Herzig KH; Müller R; Carlberg C J Mol Biol; 2007 Sep; 372(2):341-55. PubMed ID: 17669420 [TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor (PPAR) beta/delta: a new potential therapeutic target for the treatment of metabolic syndrome. Coll T; Rodrïguez-Calvo R; Barroso E; Serrano L; Eyre E; Palomer X; Vázquez-Carrera M Curr Mol Pharmacol; 2009 Jan; 2(1):46-55. PubMed ID: 20021445 [TBL] [Abstract][Full Text] [Related]
18. Recent Insights on the Role of PPAR-β/δ in Neuroinflammation and Neurodegeneration, and Its Potential Target for Therapy. Strosznajder AK; Wójtowicz S; Jeżyna MJ; Sun GY; Strosznajder JB Neuromolecular Med; 2021 Mar; 23(1):86-98. PubMed ID: 33210212 [TBL] [Abstract][Full Text] [Related]
19. The Role of Peroxisome Proliferator-Activated Receptors in Endometrial Cancer. Psilopatis I; Vrettou K; Troungos C; Theocharis S Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298140 [TBL] [Abstract][Full Text] [Related]
20. Nutritional strategies to modulate inflammation pathways via regulation of peroxisome proliferator-activated receptor β/δ. da Cruz BO; Cardozo LFMF; Magliano DC; Stockler-Pinto MB Nutr Rev; 2020 Mar; 78(3):207-214. PubMed ID: 31584650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]